retatrutide and pregnancy Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide Benefits for Women: Evidence,

doi: 10.3389/fonc.2026.1745285 Received 30 December 2025 Revised 18 December 2025 Accepted 14 January 2026 Published 11 February 2026 Volume 16 - 2026 Edited by Rohit Upadhyay, Tulane University, United States Reviewed by Seydi Ykm, Namik Kemal University, Trkiye Fatima Zahra Jawhari, Institut Suprieur des Professions Infirmires et Techniques de Sant, Morocco Updates Copyright 2026 Kmail

Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents

Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women

The GLP-1 fat loss treatment guide covers the broader class of medications and their expanding evidence base